HopeStage
Back to all studies
CompletedNCT05534126

Enhancing Cognitive Processing Therapy for PTSD Via Stellate Ganglion Block Treatment: A Pilot Trial

Placebo comparisonAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Chicago, United StatesSee all locations and recruitment
Activities
Placebo comparator
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateStarted: November 1, 2022
Recruitment status
Completed
Enrollment listed in the registry
60
Sponsor
Rush University Medical Center
Sponsor type
Hospital / academic medical center
Study type
Procedure
Intervention type
PROCEDURE
Study phase
Not clearly listed
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05534126
Official title
Show the full official title

Enhancing Cognitive Processing Therapy for Posttraumatic Stress Disorder Via Stellate Ganglion Block Treatment: A Pilot Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Chicago

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Rush University Medical Center, a hospital or academic medical center.

Who was this study for?

Listed age limits: from 18 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me